We will assess and prescribe a suitable dose
We offer Wegovy, a weekly self-injected medicine. During your consultation we measure you weight and your height. Your BMI must be at least 30 or over. We will let you know this during the consultation.
About Wegovy Pens:
Wegovy is a clinically proven weight loss medication containing the active ingredient Semaglutide. In clinical trials, patients taking Wegovy lost 15% of their body weight in 68 weeks.
Wegovy acts on receptors in your brain to suppress your appetite, reduce cravings and slow the emptying of your stomach, so you consume fewer calories and lose more weight than with dieting alone.
It also reduces your biological ‘set point’ - the point at which your body fights to maintain a certain weight - meaning that you can lose weight for longer without hitting a plateau. We recommend pairing medication with diet and exercise changes to help you keep the weight off long term.
Rigorous clinical trials have established that Wegovy is non-addictive and suitable for long-term use.
Suggested For
Weight loss
Dosage
Your dosage will increase monthly to reduce the risk of side effects: 0.25mg in month one, 0.5mg in month two, 1mg in month three. After month 3 you will have the option to remain at 1mg or to continue increasing the dosage to 1.7mg and then 2.4mg. Please note that 1mg is included in the standard subscription price, while 1.7mg and 2.4mg have a surcharge.
Application
Store in the fridge before use. Inject once a week, on the same day each week. Rotate the injection area each time (thigh, stomach, or upper arm).
Side Effects
As with all medications some people do experience side effects, however with Wegovy these tend to be mild and short term. The most common side effects are nausea, acid reflux, constipation and fatigue. Please read the patient information leaflet for more information.
Ingredients
The active substance is Semaglutide. The other ingredients are disodium phosphate dihydrate, propylene glycol, phenol, hydrochloric acid, sodium hydroxide and water.